Related Experiment Videos
A comparative study of myocardial troponin T levels in patients undergoing hemodialysis
1Third Department of Internal Medicine, Okayama University Medical School, Japan.
Insights
Myocardial troponin T (TnT) may be a superior indicator of heart injury in hemodialysis (HD) patients compared to other markers. Elevated TnT in HD patients with diabetes mellitus suggests potential arteriosclerotic lesions.
Area of Science:
- Nephrology
- Cardiology
- Clinical Biochemistry
Background:
- Patients undergoing hemodialysis (HD) are at increased risk for cardiovascular complications.
- Diabetes mellitus is a significant comorbidity in HD patients, potentially exacerbating cardiac issues.
- Accurate assessment of myocardial injury is crucial for managing cardiovascular risk in this population.
Purpose of the Study:
- To compare the efficacy of various myocardial injury markers in hemodialysis patients.
- To investigate the utility of troponin T (TnT) as a marker for myocardial injury in HD patients, particularly those with diabetes mellitus.
- To explore potential differences in myocardial injury markers between HD patients with and without diabetes mellitus.
Main Methods:
- Inclusion of three patient groups: HD without diabetes (HD-non DM), HD with diabetes (HD-DM), and diabetes without HD (DM).
- Measurement of cardiac biomarkers: troponin T (TnT), creatine kinase (CK), myoglobin (Mb), and myosin light chain-1 (MLC-1).
- Comparative analysis of biomarker levels across the study groups.
Main Results:
- Myoglobin (Mb) and myosin light chain-1 (MLC-1) were elevated in HD patients irrespective of diabetes status.
- Troponin T (TnT) showed only slight abnormalities in most HD patients but was significantly higher in the HD-DM group compared to the HD-non DM group.
- No significant correlation was observed between TnT and creatinine (Cr) in any group.
Conclusions:
- Myocardial troponin T (TnT) may serve as a more sensitive marker for myocardial injury in hemodialysis patients than currently used markers like Mb and MLC-1.
- The elevated TnT in the HD-DM group suggests a higher prevalence of arteriosclerotic lesions and myocardial injury in this subgroup.
- Further research is warranted to validate TnT's role in diagnosing and monitoring cardiac health in HD patients with diabetes.
Abstract:
This study included 25 patients receiving hemodialysis (HD) but in whom diabetes mellitus was not the primary disease (HD-non DM group), 25 patients receiving hemodialysis with diabetes mellitus as the primary disease (HD-DM group), and 50 patients with diabetes mellitus who had not yet been treated with hemodialysis (DM group). The following markers of myocardial injury were measured in these patients: troponin T (TnT), creatine kinase (CK), myoglobin (Mb), and myosin light chain-1 (MLC-1). No significant correlation was found between myocardial TnT and Cr in any study group. The Mb and MLC-1 values in patients receiving HD were markedly higher than normal regardless of the primary disease involvement, while myocardial TnT was found to be only slightly abnormal. These results suggest that myocardial TnT may be a more useful marker of myocardial injury in HD patients than the markers in current use. In the present investigation, myocardial TnT was the only marker that was higher in the HD-DM group than in the HD-non DM group. This suggests the possibility that the HD-DM group included more patients with arteriosclerotic lesions, such as myocardial injury.